DOXORUBICIN HYDROCHLORIDE (Hospira, Inc.)
Welcome to the PulseAid listing for the DOXORUBICIN HYDROCHLORIDE drug offered from Hospira, Inc.. This Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Hospira, Inc. |
| NON-PROPRIETARY NAME: | doxorubicin hydrochloride |
| SUBSTANCE NAME: | DOXORUBICIN HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] |
| ROUTE: | INTRA-ARTERIAL; INTRAVENOUS; INTRAVESICAL |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
| START MARKETING DATE: | 2016-04-18 |
| END MARKETING DATE: | 2017-12-31 |
DOXORUBICIN HYDROCHLORIDE HUMAN PRESCRIPTION DRUG Details:
| Item Description | DOXORUBICIN HYDROCHLORIDE from Hospira, Inc. |
| LABELER NAME: | Hospira, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2(mg/mL) |
| START MARKETING DATE: | 2016-04-18 |
| END MARKETING DATE: | 2017-12-31 |
| PRODUCT ID: | 0409-0124_21dea217-18e8-431a-8445-3b9d2871aed3 |
| PRODUCT NDC: | 0409-0124 |
| APPLICATION NUMBER: | |
Other DOXORUBICIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
